N. Amar

911 total citations
9 papers, 648 citations indexed

About

N. Amar is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, N. Amar has authored 9 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 5 papers in Immunology and Allergy and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in N. Amar's work include Allergic Rhinitis and Sensitization (5 papers), Asthma and respiratory diseases (5 papers) and Respiratory and Cough-Related Research (3 papers). N. Amar is often cited by papers focused on Allergic Rhinitis and Sensitization (5 papers), Asthma and respiratory diseases (5 papers) and Respiratory and Cough-Related Research (3 papers). N. Amar collaborates with scholars based in United States, France and Kenya. N. Amar's co-authors include Alan Kivitz, Scott Mellis, Neil Stahl, Hal M. Hoffman, George D. Yancopoulos, Steven P. Weinstein, Arthur Kavanaugh, Harry Sacks, William J. Wheeler and Julius van Bavel and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Annals of Allergy Asthma & Immunology and Telemedicine Journal and e-Health.

In The Last Decade

N. Amar

9 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Amar United States 4 344 227 199 189 171 9 648
Zana Brkić Netherlands 11 138 0.4× 297 1.3× 355 1.8× 8 0.0× 19 0.1× 17 743
Antónia Szántó Hungary 12 46 0.1× 253 1.1× 239 1.2× 10 0.1× 34 0.2× 30 607
H Schotte Germany 11 36 0.1× 140 0.6× 47 0.2× 19 0.1× 27 0.2× 19 349
R. Fakhfakh Tunisia 13 180 0.5× 190 0.8× 88 0.4× 22 0.1× 17 0.1× 50 473
Ildikó Fanny Horváth Hungary 12 39 0.1× 177 0.8× 160 0.8× 14 0.1× 35 0.2× 18 465
Müge Bıçakçıgil Türkiye 8 23 0.1× 95 0.4× 82 0.4× 19 0.1× 14 0.1× 11 379
Ilaria Mormile Italy 12 38 0.1× 116 0.5× 70 0.4× 42 0.2× 23 0.1× 39 349
Yuya Fujita Japan 14 185 0.5× 254 1.1× 22 0.1× 9 0.0× 55 0.3× 78 554

Countries citing papers authored by N. Amar

Since Specialization
Citations

This map shows the geographic impact of N. Amar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Amar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Amar more than expected).

Fields of papers citing papers by N. Amar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Amar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Amar. The network helps show where N. Amar may publish in the future.

Co-authorship network of co-authors of N. Amar

This figure shows the co-authorship network connecting the top 25 collaborators of N. Amar. A scholar is included among the top collaborators of N. Amar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Amar. N. Amar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Jain, Neal, et al.. (2019). P211 EFFICACY AND SAFETY OF MOMETASONE FUROATE/FORMOTEROL COMPARED WITH MOMETASONE FUROATE IN CHILDREN WITH PERSISTENT ASTHMA. Annals of Allergy Asthma & Immunology. 123(5). S35–S35. 1 indexed citations
3.
Segall, Nathan, et al.. (2012). Once Daily Treatment with Beclomethasone Dipropionate Hydrofluoroalkane Nasal Aerosol Is Safe and Effective in Children (6-11 Years of Age) With Seasonal Allergic Rhinitis. Journal of Allergy and Clinical Immunology. 129(2). AB188–AB188. 2 indexed citations
4.
Hampel, Frank C., Paul H. Ratner, Julius van Bavel, et al.. (2010). Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Annals of Allergy Asthma & Immunology. 105(2). 168–173. 93 indexed citations
5.
Bavel, Julius van, William C. Howland, N. Amar, William J. Wheeler, & Harry Sacks. (2009). Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis. Allergy and Asthma Proceedings. 30(5). 512–518. 14 indexed citations
6.
Ratner, Paul H., Frank C. Hampel, Julius van Bavel, et al.. (2008). Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Annals of Allergy Asthma & Immunology. 100(1). 74–81. 90 indexed citations
7.
Hoffman, Hal M., N. Amar, Alan Kivitz, et al.. (2008). Efficacy and safety of rilonacept (interleukin‐1 trap) in patients with cryopyrin‐associated periodic syndromes: Results from two sequential placebo‐controlled studies. Arthritis & Rheumatism. 58(8). 2443–2452. 442 indexed citations
8.
Hoffman, Henry T., N. Amar, Rosalind Cartwright, et al.. (2008). Durability of Response to Rilonacept (IL-1 Trap) in a Phase 3 Study of Patients with Cryopyrin-Associated Periodic Syndromes (CAPS): Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS). Journal of Allergy and Clinical Immunology. 121(2). S175–S175. 3 indexed citations
9.
Ratner, Paul H., Frank C. Hampel, N. Amar, et al.. (2004). Olopatadine HCl nasal spray is effective and safe for the treatment of seasonal (Mountain Cedar) allergic rhinitis. Journal of Allergy and Clinical Immunology. 113(2). S200–S201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026